Loading...
Epirubicin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Epirubicin
2025-Q4
Comprehensive analysis of India’s epirubicin export trade — suppliers, buyers, prices, routes, and every shipment record.
55
Shipments
$666K
Trade Value
26
Suppliers
22
Buyers
29
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/epirubicin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s epirubicin trade — 2025-Q4
KEY TAKEAWAY
Epirubicin 2025-Q4 exports total $666.0K across 29 countries, with MYLAN LABORATORIES LTD commanding 62.7% market share.
TOTAL SHIPMENTS
55
2025-Q4
EXPORT VALUE
$666.0K
FOB USD
TOTAL QUANTITY
68.8K
units shipped
INDIAN SUPPLIERS
26
unique exporters
GLOBAL BUYERS
22
unique importers
DESTINATIONS
29
countries
MEDIAN UNIT PRICE
$6.27
per unit
TOP-5 SHARE
97.0%
of total USD
BRANDED SHARE
61.8%
34 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
MYLAN LABORATORIES LTD is India's #1 Epirubicin exporter with $417.8K (62.7% market share).→ §5, Indian Supplier Rankings
2
Epirubicin reached 29 countries, with France as the top destination ($279.4K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4419) — top 10 suppliers control 98.8% of exports.→ §5, Indian Supplier Rankings
4
90.9% of buyers (20 of 22) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (79.1%) across 3 dosage forms.→ §7, Price Benchmarks
6
29 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MYLAN LABORATORIES LTD leads in volume — how do 26 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian epirubicin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Epirubicin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial epirubicin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian epirubicin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Epirubicin India trade report
Product scope
Epirubicin
All variants merged — branded and generic formulations of epirubicin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
55
Every commercial epirubicin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $48.4K, Nov $163.7K, Dec $453.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$48.4K
Oct USD
8 shipments
2
$163.7K
Nov USD
+238.4% MoM
3
$453.9K
Dec USD
+177.2% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 238.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $48K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $666K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $115K rise in Nov, $290K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $48K | 8 shipments |
| Nov | $164K | 13 shipments |
| Dec | $454K | 34 shipments |
| Q4 Total | $666K | 55 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Nepal held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MYLAN LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import epirubicin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
France absorbs 42.0% of India’s 2025-Q4 epirubicin trade ($279.4K). Beyond the top 10 destinations, 29 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 29 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much epirubicin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$51K
7.7% of trade
9 countries · 20 shipments
Europe
$418K
62.7% of trade
3 countries · 6 shipments
Americas
$45K
6.8% of trade
2 countries · 5 shipments
Africa
$150K
22.6% of trade
14 countries · 23 shipments
Oceania
$1K
0.2% of trade
1 countries · 1 shipments
Fig 4.1 France is the #1 corridor ($279K) — 29 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian epirubicin it receives (light = low, dark = high). Orange arcs radiate from India to the top 29 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | France | $279K | 4 | MYLAN LABORATORIES LTD | $279K | — | — | — | — |
| 2 | Netherlands | $138K | 1 | MYLAN LABORATORIES LTD | $138K | — | — | — | — |
| 3 | Morocco | $89K | 1 | VENUS REMEDIES LTD | $89K | — | — | — | — |
| 4 | South Africa | $53K | 1 | INTAS PHARMACEUTICALS LTD | $53K | — | — | — | — |
| 5 | Brazil | $45K | 1 | INTAS PHARMACEUTICALS LTD | $45K | — | — | — | — |
| 6 | Philippines | $18K | 1 | ADMAC LIFESCIENCES | $18K | — | — | — | — |
| 7 | Malaysia | $17K | 1 | VENUS REMEDIES LTD | $17K | — | — | — | — |
| 8 | Burundi | $4K | 2 | KHANDELWAL LABORATORIES PVT LTD | $4K | — | — | — | — |
| 9 | Sri Lanka | $3K | 1 | UNITED BIOTECH PVT LTD | $3K | — | — | — | — |
| 10 | Nepal | $3K | 6 | GETWELL PHARMA INDIA PVT LTD | $2K | NAPROD LIFE SCIENCES PVT LTD | $910 | UNITED BIOTECH PVT LTD | $362 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 7.7% of USD — but France is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
42.0%
#1 country share
France alone
90.9%
Top 5 share
5 of 29 countries
99.4%
Top 15 share
Long tail of 14 countries = 0.6%
HHI 2496
Destination HHI
Moderately concentrated
29
Countries served
Global pharma reach from India
14
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
26 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MYLAN LABORATORIES LTD ($417.8K, 62.7% share) and VENUS REMEDIES LTD ($106.5K) together control 78.7% of India’s 2025-Q4 epirubicin trade. The top 5 suppliers hold 97.0%. 26 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian epirubicin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MYLAN LABORATORIES LTD leads by $311K over VENUS REMEDIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: AMRS HEALTHCARE PVT is #16 by value but #5 by volume.
Fig 5.2 MYLAN LABORATORIES LTD also leads by shipment count (5) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: AMRS HEALTHCARE PVT moves from #5 by volume to #16 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 26 epirubicin suppliers split into strategic segments
KEY TAKEAWAY
7 suppliers (25%) generate 97.9% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MYLAN LABORATORIES LTD and VENUS REMEDIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.9% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LTD | 2 | 2 | $418K |
| 2 | VENUS REMEDIES LTD | 1 | 2 | $107K |
| 3 | INTAS PHARMACEUTICALS LTD | 1 | 3 | $98K |
| 4 | ADMAC LIFESCIENCES | 1 | 2 | $20K |
| 5 | UNITED BIOTECH PVT LTD | 1 | 2 | $4K |
| 6 | KHANDELWAL LABORATORIES PVT LTD | 1 | 1 | $4K |
| 7 | GALAXY SUPER SPECIALITY | 1 | 1 | $3K |
| 8 | GETWELL PHARMA INDIA PVT LTD | 1 | 2 | $2K |
| 9 | BIOZENTA LIFESCIENCE PVT LTD | 1 | 2 | $2K |
| 10 | CITRO PHARMA PVT LTD | 1 | 1 | $2K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the epirubicin manufacturing hubs
KEY TAKEAWAY
Bangalore and Behra together account for $526K of India’s 2025-Q4 epirubicin trade.
Fig 5.5 Bangalore (2 exporters, $420K) and Behra (1 exporters, $107K) are India’s epirubicin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
97.0%
Top 5 share
5 of 26 suppliers
98.8%
Top 10 share
10 of 26 suppliers
97.9%
Top 25% share
7 suppliers = 98% USD
HHI 4419
Supplier HHI
Concentrated
26
Total suppliers
shipped Epirubicin in 2025-Q4
18+ cities
Indian hubs
Bangalore and Behra lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MYLAN LABORATORIES LTD | $418K |
#1
EXPORTER PROFILE #1 OF 1
MYLAN LABORATORIES LTD
Bangalore · India’s #1 epirubicin supplier by USD · 2025-Q4
2025-Q4 USD
$418K
62.7% market share
SHIPMENTS
5
avg $84K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
0%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
France is the #1 market at $279K (67% of trade), followed by Netherlands at $138K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | France | $279K | 4 | 66.9% |
| 2 | Netherlands | $138K | 1 | 33.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $279K.
PRODUCT MIX
Injection dominates at 67% of trade. Solution (33.1%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CSP P/O VIATRIS SA | France | $279K | ⚠ Locked |
| MYLAN IRELAND LTD | Netherlands | $138K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
MYLAN LABORATORIES LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 France absorbs $279K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
22 importers across 29 countries — who is buying Indian epirubicin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 20 importers together hold only 70.5% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian epirubicin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 CSP P/O VIATRIS SA is the #1 importer at $279K (42.0%) — top 20 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 20 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
20 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
5%
Multi-source (3–4)
1 buyers diversified across 3–4
5%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source epirubicin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Nepal 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| VISION CARE INTERNATIO… | GETWELL PHARMA INDIA… | $2K | $5.123 | Injection |
| DKM PHARMACEUTICALS PV… | NAPROD LIFE SCIENCES… | $909.970 | $5.055 | hydrochloride |
| NIKHIL PHARMA PVT LTD | UNITED BIOTECH PVT LTD | $361.976 | $5.171 | — |
United Arab Emirates 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ANSYNC GLOBAL FZCO | OCEAN PHARMACEUTICAL | $1K | $6.273 | Injection |
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $278.151 | $6.954 | Injection |
France 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CSP P/O VIATRIS SA | MYLAN LABORATORIES LTD | $279K | $28.203 | Injection |
Netherlands 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MYLAN IRELAND LTD | MYLAN LABORATORIES LTD | $138K | $7.258 | Solution |
Philippines 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMASTAR INTL TRADIN… | ADMAC LIFESCIENCES | $18K | $12.404 | Injection |
§6.3 Price positioning — top 20 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | CSP P/O VIATRIS SA | France | $279K | $70K | Premium |
| 2 | MYLAN IRELAND LTD | Netherlands | $138K | $138K | Premium |
| 3 | PHARMASTAR INTL TRAD… | Philippines | $18K | $18K | Mid |
| 4 | M.E.L.S.B | Malaysia | $17K | $17K | Mid |
| 5 | LOTUS PHARMA | Burundi | $4K | $2K | Budget |
| 6 | BANK OF CEYLON-TRADE… | Sri Lanka | $3K | $3K | Budget |
| 7 | VISION CARE INTERNAT… | Nepal | $2K | $1K | Budget |
| 8 | DALIAN CHAOHONGSUPPL… | China | $2K | $2K | Budget |
| 9 | GREBN SIGNALCO LTD | Myanmar | $1K | $1K | Budget |
| 10 | ANSYNC GLOBAL FZCO | United Arab Emirates | $1K | $627.000 | Budget |
| 11 | DKM PHARMACEUTICALS … | Nepal | $909.970 | $910.000 | Budget |
| 12 | NIKHIL PHARMA PVT LTD | Nepal | $361.976 | $121.000 | Budget |
| 13 | MEDIMART DRUG STORE | United Arab Emirates | $278.151 | $278.000 | Budget |
| 14 | SALAMA NIGERIA LTD | Benin | $273.917 | $274.000 | Budget |
| 15 | NDZENGUE EBEDE JEAN … | Cameroon | $267.235 | $134.000 | Budget |
| 16 | AL-NOOR FOR DRUGS & … | Yemen | $191.238 | $191.000 | Budget |
| 17 | TAIWO ADEYEMI | Nigeria | $177.259 | $177.000 | Budget |
| 18 | EUROFINS BIOPHARMA P… | Hungary | $13.766 | $14.000 | Budget |
| 19 | HANITRA RAZAOARIMANANA | Madagascar | $1.903 | $1.000 | Budget |
| 20 | BAWABAT ALDAWA MEDIC… | United Arab Emirates | $0.0000 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MYLAN LABORATORIES LTD → CSP P/O VIATRIS SA is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian epirubicin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Epirubicin prices span 1049× ($0.028 → $29.07). The coefficient of variation is 1.03. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.028 | Lowest observed unit price |
| P5 | $0.056 | 5th percentile |
| P25 | $1.79 | 25th percentile (Q1) |
| Median | $6.27 | 50th percentile (Q2) |
| P75 | $8.94 | 75th percentile (Q3) |
| P95 | $27.42 | 95th percentile |
| Max | $29.07 | Highest observed unit price |
| Mean | $7.08 | Arithmetic average |
| CV | 103% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MYLAN LABORATORIES LTD prices at $23.71/unit vs market median $6.27.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. UNITED BIOTECH PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MYLAN LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. NAPROD LIFE SCIENCES Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. GALAXY SUPER SPECIALITY Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | MYLAN LABORATORI… | France | Injection | 5K | $137K | $29.07 | Sterile formulation premium |
| Dec 2025 | MYLAN LABORATORI… | France | Injection | 2K | $43K | $27.42 | Sterile formulation premium |
| Dec 2025 | MYLAN LABORATORI… | France | Injection | 2K | $49K | $27.42 | Sterile formulation premium |
| Dec 2025 | MYLAN LABORATORI… | France | Injection | 2K | $50K | $27.42 | Sterile formulation premium |
| Oct 2025 | CITRO PHARMA PVT… | Mauritius | Injection | 2 | $31.63 | $15.82 | Sterile formulation premium |
| Nov 2025 | RUN MEDWAY | Cameroon | Injection | 10 | $133.62 | $13.36 | Sterile formulation premium |
| Nov 2025 | RUN MEDWAY | Cameroon | Injection | 10 | $133.62 | $13.36 | Sterile formulation premium |
| Nov 2025 | ADMAC LIFESCIENCES | Philippines | Injection | 1K | $18K | $12.40 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Brazil | Injection | 4K | $45K | $12.36 | Sterile formulation premium |
| Dec 2025 | UNITED BIOTECH P… | Nepal | Injection | 20 | $233.90 | $11.69 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Injection | 3K | $79.16 | $0.028 | Sterile formulation premium |
| Dec 2025 | S. HIMATLAL HEAL… | Ethiopia | Injection | 100 | $4.92 | $0.049 | Sterile formulation premium |
| Dec 2025 | BRUCK PHARMA PVT… | Cote d'Ivoire | Injection | 3 | $0.150 | $0.050 | Sterile formulation premium |
| Dec 2025 | BIOZENTA LIFESCI… | Egypt | Injection | 530 | $31.93 | $0.060 | Sterile formulation premium |
| Dec 2025 | V S INTERNATIONA… | Nigeria | Injection | 2K | $177.26 | $0.089 | Sterile formulation premium |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Injection | 525 | $52.17 | $0.099 | Sterile formulation premium |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Injection | 1K | $148.46 | $0.099 | Sterile formulation premium |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Injection | 1K | $148.16 | $0.099 | Sterile formulation premium |
| Dec 2025 | BRUCK PHARMA PVT… | Cote d'Ivoire | Injection | 1 | $0.105 | $0.105 | Sterile formulation premium |
| Nov 2025 | GETWELL PHARMA I… | Madagascar | Injection | 4 | $0.865 | $0.216 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship epirubicin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Epirubicin leaves India through 7+ ports. The top 5 (BANGALORE ICD, BANGALORE AIR, DELHI AIR) handle 99.7% of total USD. AIR moves 85% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 BANGALORE ICD handles $279K — top 7 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 FOS SUR MER is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 85% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$385K
57.8% of USD · 85.5% of ships
ICD
$279K
42.0% of USD · 7.3% of ships
SEA
$2K
0.2% of USD · 7.3% of ships
Fig 8.3 The dominant corridor is BANGALORE ICD → Sea → Europe ($279K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Mauritius is the most concentrated destination (HHI 10000, 1 suppliers). Nepal is the most competitive (HHI 4677).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Mauritius (HHI 10,000) is the most concentrated — Nepal (HHI 4,677) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| CSP P/O VIATRIS SA | France | MYLAN LABORATORI… | $279K | 4 | HIGH |
| MYLAN IRELAND LTD | Netherlands | MYLAN LABORATORI… | $138K | 1 | HIGH |
| PHARMASTAR INTL TRAD… | Philippines | ADMAC LIFESCIENCES | $18K | 1 | MEDIUM |
| M.E.L.S.B | Malaysia | VENUS REMEDIES LTD | $17K | 1 | MEDIUM |
| LOTUS PHARMA | Burundi | KHANDELWAL LABOR… | $4K | 2 | MEDIUM |
| BANK OF CEYLON-TRADE… | Sri Lanka | UNITED BIOTECH P… | $3K | 1 | MEDIUM |
| VISION CARE INTERNAT… | Nepal | GETWELL PHARMA I… | $2K | 2 | MEDIUM |
| DALIAN CHAOHONGSUPPL… | China | JMB PHARMACEUTIC… | $2K | 1 | MEDIUM |
Conclusion: 20 buyers depend on exactly one Indian supplier, representing $469K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| France | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Morocco | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burundi | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tajikistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| China | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in France | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Mauritius lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter France (1 suppliers) | This Q | HIGH |
| A6 | Enter Netherlands (1 suppliers) | This Q | MED |
| A8 | Build Netherlands distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for France tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | France | Other | 1 | $279K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Netherlands | Other | 1 | $138K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Morocco | Africa | 1 | $89K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | South Africa | Africa | 1 | $53K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Brazil | Other | 1 | $45K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Philippines | Asia | 1 | $18K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Malaysia | Asia | 1 | $17K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | United Arab Emirates | Other | 3 | $2K | +351% | LOW | Growing 351% with only 3 competitors |
| 9 | Burundi | Africa | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Sri Lanka | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nepal | Asia | 3 | $3K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 12 | Myanmar | Asia | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Tajikistan | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Mauritius | Africa | 1 | $2K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | China | Asia | 1 | $2K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 55 2025-Q4 Epirubicin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/epirubicin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 55 2025-Q4 epirubicin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian epirubicin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
55
across all regions
TOTAL USD
$666K
2025-Q4 FOB value
UNITS
68.8K
tablets, capsules, etc.
SUPPLIERS
26
Indian exporters
BUYERS
22
global importers
COUNTRIES
29
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $150K (22.6%), spanning 14 countries.
26 Indian suppliers shipped to 22 buyers across 29 countries — average shipment value $12K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
14 countries · 23 shipments · $150K · 15 Indian suppliers · 7 buyers
SHIPMENTS
23
USD
$150K
COUNTRIES
14
SUPPLIERS
15
BUYERS
7
HHI
4,773
concentrated
Top 14 destination countries in Africa
1
Morocco (59.2%)
$89K
2
South Africa (35.5%)
$53K
3
Burundi (2.5%)
$4K
4
Mauritius (1.2%)
$2K
5
Kenya (0.7%)
$980.99
6
Togo (0.3%)
$389.64
7
Ethiopia (0.2%)
$346.25
8
Benin (0.2%)
$273.92
9
Cameroon (0.2%)
$267.24
10
Nigeria (0.1%)
$177.26
11
Egypt (0.0%)
$31.93
12
Madagascar (0.0%)
$1.90
13
DR Congo (0.0%)
$0.862
14
Cote d'Ivoire (0.0%)
$0.254
Top 15 Indian suppliers into Africa
1
VENUS REMEDIES LTD
$89K
2
INTAS PHARMACEUTICALS LTD
$53K
3
KHANDELWAL LABORATORIES PVT LTD
$4K
4
CITRO PHARMA PVT LTD
$2K
5
R.S. SURGIPHARM PVT LTD
$980.99
6
PHARMEDA HEALTHCARE PVT LTD
$389.64
7
MATOSHREE HEALTH CARE PVT LTD
$341.33
8
ZAHIDI ENTERPRISE
$273.92
9
RUN MEDWAY
$267.24
10
V S INTERNATIONAL PVT LTD
$177.26
11
BIOZENTA LIFESCIENCE PVT LTD
$31.93
12
S. HIMATLAL HEALTHCARE LLP
$4.92
13
GETWELL PHARMA INDIA PVT LTD
$1.90
14
YOGI CARE PHARMACEUTICAL PVT LTD
$0.862
15
BRUCK PHARMA PVT LTD
$0.254
Top 5 Africa importers
1
LOTUS PHARMA · Burundi
$4K
2
SALAMA NIGERIA LTD · Benin
$273.92
3
NDZENGUE EBEDE JEAN JOEL · Cameroon
$267.24
4
TAIWO ADEYEMI · Nigeria
$177.26
5
HANITRA RAZAOARIMANANA · Madagascar
$1.90
Top 1 dosage forms
1
Injection
$150K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $2K | $358.83 |
| Nov | 7 | $4K | $624.34 |
| Dec | 11 | $144K | $13K |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VENUS REMEDIES LTD · 1 shipments · $89K | |||||||||||
| 1 | Dec 2025 | UNKNOWN BUYER | Morocco | Injection | 10.1K | NOS | $8.79 | $89K | DELHI AIR | CASABLANCA | AIR |
| SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 1 shipments · $53K | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | South Africa | Injection | 6.0K | VLS | $8.90 | $53K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #3 — KHANDELWAL LABORATORIES PVT LTD · 2 shipments · $4K | |||||||||||
| 3 | Nov 2025 | LOTUS PHARMA | Burundi | Injection | 500 | VLS | $2.97 | $1K | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 4 | Nov 2025 | LOTUS PHARMA | Burundi | Injection | 500 | VLS | $4.45 | $2K | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #4 — CITRO PHARMA PVT LTD · 4 shipments · $2K | |||||||||||
| 5 | Oct 2025 | UNLISTED BUYER | Mauritius | Injection | 150 | NOS | $8.76 | $1K | BANGALORE AIR | MAURITIUS | AIR |
| 6 | Oct 2025 | UNLISTED BUYER | Mauritius | Injection | 40 | NOS | $9.07 | $362.68 | BANGALORE AIR | MAURITIUS | AIR |
| 7 | Oct 2025 | UNLISTED BUYER | Mauritius | Injection | 8 | NOS | $10.63 | $85.02 | BANGALORE AIR | MAURITIUS | AIR |
| 8 | Oct 2025 | UNLISTED BUYER | Mauritius | Injection | 2 | NOS | $15.82 | $31.63 | BANGALORE AIR | MAURITIUS | AIR |
| SUPPLIER #5 — R.S. SURGIPHARM PVT LTD · 2 shipments · $980.99 | |||||||||||
| 9 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $5.28 | $528.16 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $4.53 | $452.84 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #6 — PHARMEDA HEALTHCARE PVT LTD · 1 shipments · $389.64 | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Togo | Injection | 50 | PCS | $7.79 | $389.64 | DELHI AIR | LOME | AIR |
| SUPPLIER #7 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $341.33 | |||||||||||
| 12 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Injection | 50 | NOS | $6.83 | $341.33 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #8 — ZAHIDI ENTERPRISE · 1 shipments · $273.92 | |||||||||||
| 13 | Dec 2025 | SALAMA NIGERIA LTD | Benin | Injection | 50 | NOS | $5.48 | $273.92 | MUMBAI AIR (SAHAR) | COTONOU | AIR |
| SUPPLIER #9 — RUN MEDWAY · 2 shipments · $267.24 | |||||||||||
| 14 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 10 | NOS | $13.36 | $133.62 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 15 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 10 | NOS | $13.36 | $133.62 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #10 — V S INTERNATIONAL PVT LTD · 1 shipments · $177.26 | |||||||||||
| 16 | Dec 2025 | TAIWO ADEYEMI | Nigeria | Injection | 2.0K | VLS | $0.089 | $177.26 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #11 — BIOZENTA LIFESCIENCE PVT LTD · 1 shipments · $31.93 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Egypt | Injection | 530 | VLS | $0.060 | $31.93 | DELHI AIR | CAIRO | AIR |
| SUPPLIER #12 — S. HIMATLAL HEALTHCARE LLP · 1 shipments · $4.92 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Ethiopia | Injection | 100 | NOS | $0.049 | $4.92 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #13 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $1.90 | |||||||||||
| 19 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.216 | $0.865 | DELHI AIR | ANTANANARIVO | AIR |
| 20 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.260 | $1.04 | DELHI AIR | ANTANANARIVO | AIR |
| SUPPLIER #14 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $0.862 | |||||||||||
| 21 | Oct 2025 | UNLISTED BUYER | DR Congo | Injection | 2 | NOS | $0.431 | $0.862 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
| SUPPLIER #15 — BRUCK PHARMA PVT LTD · 2 shipments · $0.254 | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 1 | NOS | $0.105 | $0.105 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| 23 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 3 | NOS | $0.050 | $0.150 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
9 countries · 20 shipments · $51K · 12 Indian suppliers · 13 buyers
SHIPMENTS
20
USD
$51K
COUNTRIES
9
SUPPLIERS
12
BUYERS
13
HHI
2,722
concentrated
Top 9 destination countries in Asia
1
Philippines (35.2%)
$18K
2
Malaysia (34.0%)
$17K
3
Sri Lanka (6.7%)
$3K
4
Nepal (6.5%)
$3K
5
Myanmar (6.4%)
$3K
6
Tajikistan (4.9%)
$3K
7
United Arab Emirates (3.0%)
$2K
8
China (3.0%)
$2K
9
Yemen (0.4%)
$191.24
Top 12 Indian suppliers into Asia
1
ADMAC LIFESCIENCES
$20K
2
VENUS REMEDIES LTD
$17K
3
UNITED BIOTECH PVT LTD
$4K
4
GALAXY SUPER SPECIALITY
$3K
5
GETWELL PHARMA INDIA PVT LTD
$2K
6
BIOZENTA LIFESCIENCE PVT LTD
$2K
7
JMB PHARMACEUTICALS PVT LTD
$2K
8
OCEAN PHARMACEUTICAL
$1K
9
NAPROD LIFE SCIENCES PVT LTD
$909.97
10
DROPS PHARMA PVT LTD
$278.15
11
J.A. UNITED EXPORTS PVT LTD
$191.24
12
MCARE IMPEX PVT LTD
$0.0000
Top 12 Asia importers
1
PHARMASTAR INTL TRADING CORP · Philippines
$18K
2
M.E.L.S.B · Malaysia
$17K
3
BANK OF CEYLON-TRADE SERVICES · Sri Lanka
$3K
4
VISION CARE INTERNATIONAL PVT LTD · Nepal
$2K
5
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$2K
6
GREBN SIGNALCO LTD · Myanmar
$1K
7
ANSYNC GLOBAL FZCO · United Arab Emirates
$1K
8
DKM PHARMACEUTICALS PVT LTD · Nepal
$909.97
9
NIKHIL PHARMA PVT LTD · Nepal
$361.98
10
MEDIMART DRUG STORE · United Arab Emirates
$278.15
11
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$191.24
12
BAWABAT ALDAWA MEDICINEES STORE LLC · United Arab Emirates
$0.0000
Top 3 dosage forms
1
Injection
$50K
2
hydrochloride
$909.97
3
Unknown
$76.70
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $2K | $899.77 |
| Nov | 5 | $21K | $4K |
| Dec | 13 | $29K | $2K |
Shipment register · 20 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ADMAC LIFESCIENCES · 2 shipments · $20K | |||||||||||
| 1 | Nov 2025 | PHARMASTAR INTL TRADING CORP | Philippines | Injection | 1.5K | VLS | $12.40 | $18K | DELHI AIR | MANILA | AIR |
| 2 | Nov 2025 | GREBN SIGNALCO LTD | Myanmar | Injection | 400 | VLS | $3.54 | $1K | DELHI AIR | YANGON | AIR |
| SUPPLIER #2 — VENUS REMEDIES LTD · 1 shipments · $17K | |||||||||||
| 3 | Dec 2025 | M.E.L.S.B | Malaysia | Injection | 1.8K | NOS | $9.62 | $17K | DELHI AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #3 — UNITED BIOTECH PVT LTD · 4 shipments · $4K | |||||||||||
| 4 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | 30 | PCS | $2.56 | $76.70 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR | |
| 5 | Dec 2025 | BANK OF CEYLON-TRADE SERVICES | Sri Lanka | Injection | 1.3K | NOS | $2.65 | $3K | DELHI AIR | COLOMBO | AIR |
| 6 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 20 | NOS | $2.57 | $51.37 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 7 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 20 | NOS | $11.69 | $233.90 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #4 — GALAXY SUPER SPECIALITY · 1 shipments · $3K | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Tajikistan | Injection | 400 | NOS | $6.35 | $3K | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #5 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $2K | |||||||||||
| 9 | Nov 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 200 | NOS | $2.21 | $441.20 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 10 | Dec 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 200 | NOS | $8.04 | $2K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #6 — BIOZENTA LIFESCIENCE PVT LTD · 1 shipments · $2K | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Myanmar | Injection | 300 | VLS | $6.29 | $2K | DELHI AIR | YANGON | AIR |
| SUPPLIER #7 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $2K | |||||||||||
| 12 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Injection | 500 | NOS | $3.04 | $2K | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 13 | Dec 2025 | UNLISTED BUYER | China | Injection | 1.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 14 | Dec 2025 | UNLISTED BUYER | China | Injection | 1.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #8 — OCEAN PHARMACEUTICAL · 2 shipments · $1K | |||||||||||
| 15 | Dec 2025 | ANSYNC GLOBAL FZCO | United Arab Emirates | Injection | 140 | NOS | $6.27 | $878.20 | AHMEDABAD AIR | SHARJAH | AIR |
| 16 | Dec 2025 | ANSYNC GLOBAL FZCO | United Arab Emirates | Injection | 60 | NOS | $6.27 | $376.37 | AHMEDABAD AIR | SHARJAH | AIR |
| SUPPLIER #9 — NAPROD LIFE SCIENCES PVT LTD · 1 shipments · $909.97 | |||||||||||
| 17 | Nov 2025 | DKM PHARMACEUTICALS PVT LTD | Nepal | hydrochloride | 180 | VLS | $5.06 | $909.97 | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #10 — DROPS PHARMA PVT LTD · 1 shipments · $278.15 | |||||||||||
| 18 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 40 | NOS | $6.95 | $278.15 | COCHIN SEA | DUBAI | AIR |
| SUPPLIER #11 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $191.24 | |||||||||||
| 19 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 30 | NOS | $6.37 | $191.24 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #12 — MCARE IMPEX PVT LTD · 1 shipments · $0.0000 | |||||||||||
| 20 | Dec 2025 | BAWABAT ALDAWA MEDICINEES STORE LLC | United Arab Emirates | Injection | 5 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 6 shipments · $418K · 2 Indian suppliers · 3 buyers
SHIPMENTS
6
USD
$418K
COUNTRIES
3
SUPPLIERS
2
BUYERS
3
HHI
9,999
concentrated
Top 3 destination countries in Europe
1
France (66.9%)
$279K
2
Netherlands (33.1%)
$138K
3
Hungary (0.0%)
$13.77
Top 2 Indian suppliers into Europe
1
MYLAN LABORATORIES LTD
$418K
2
INTAS PHARMACEUTICALS LTD
$13.77
Top 3 Europe importers
1
CSP P/O VIATRIS SA · France
$279K
2
MYLAN IRELAND LTD · Netherlands
$138K
3
EUROFINS BIOPHARMA PRODUCT TESTIN · Hungary
$13.77
Top 2 dosage forms
1
Injection
$279K
2
Solution
$138K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $138K | $138K |
| Dec | 5 | $279K | $56K |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MYLAN LABORATORIES LTD · 5 shipments · $418K | |||||||||||
| 1 | Nov 2025 | MYLAN IRELAND LTD | Netherlands | Solution | 19.1K | NOS | $7.26 | $138K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| 2 | Dec 2025 | CSP P/O VIATRIS SA | France | Injection | 4.7K | NOS | $29.07 | $137K | BANGALORE ICD | FOS SUR MER | ICD |
| 3 | Dec 2025 | CSP P/O VIATRIS SA | France | Injection | 1.6K | NOS | $27.42 | $43K | BANGALORE ICD | FOS SUR MER | ICD |
| 4 | Dec 2025 | CSP P/O VIATRIS SA | France | Injection | 1.8K | NOS | $27.42 | $50K | BANGALORE ICD | FOS SUR MER | ICD |
| 5 | Dec 2025 | CSP P/O VIATRIS SA | France | Injection | 1.8K | NOS | $27.42 | $49K | BANGALORE ICD | FOS SUR MER | ICD |
| SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 1 shipments · $13.77 | |||||||||||
| 6 | Dec 2025 | EUROFINS BIOPHARMA PRODUCT TESTIN | Hungary | Injection | 25 | NOS | $0.551 | $13.77 | AHMEDABAD AIR | BUDAPEST, | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
2 countries · 5 shipments · $45K · 2 Indian suppliers · 1 buyers
SHIPMENTS
5
USD
$45K
COUNTRIES
2
SUPPLIERS
2
BUYERS
1
HHI
9,812
concentrated
Top 2 destination countries in Americas
1
Brazil (99.1%)
$45K
2
Venezuela (0.9%)
$427.95
Top 2 Indian suppliers into Americas
1
INTAS PHARMACEUTICALS LTD
$45K
2
AMRS HEALTHCARE PVT LTD
$427.95
Top 0 Americas importers
Top 1 dosage forms
1
Injection
$45K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $45K | $45K |
| Nov | 0 | $0.0000 | — |
| Dec | 4 | $427.95 | $106.99 |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 1 shipments · $45K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Brazil | Injection | 3.6K | VLS | $12.36 | $45K | AHMEDABAD AIR | GUARULHOS | AIR |
| SUPPLIER #2 — AMRS HEALTHCARE PVT LTD · 4 shipments · $427.95 | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Venezuela | Injection | 2.9K | NOS | $0.028 | $79.16 | DELHI AIR | CARACAS | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Venezuela | Injection | 1.5K | NOS | $0.099 | $148.16 | DELHI AIR | CARACAS | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Venezuela | Injection | 1.5K | NOS | $0.099 | $148.46 | DELHI AIR | CARACAS | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Venezuela | Injection | 525 | NOS | $0.099 | $52.17 | DELHI AIR | CARACAS | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $1K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$1K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$1K
Top 1 Indian suppliers into Oceania
1
BRUCK PHARMA PVT LTD
$1K
Top 0 Oceania importers
Top 1 dosage forms
1
Injection
$1K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $1K | $1K |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 1 shipments · $1K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Injection | 150 | NOS | $7.14 | $1K | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 26 Indian epirubicin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped epirubicin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LTD | BANGALORE | 5 | $418K | Solution, Injection | Europe |
| 2 | VENUS REMEDIES LTD | Behra | 2 | $107K | Injection | Asia, Africa |
| 3 | INTAS PHARMACEUTICALS LTD | AHMEDABAD | 3 | $98K | Injection | Americas, Europe |
| 4 | ADMAC LIFESCIENCES | BADDI | 2 | $20K | Injection | Asia |
| 5 | UNITED BIOTECH PVT LTD | NEW DELHI | 4 | $4K | Injection | Asia |
| 6 | KHANDELWAL LABORATORIES PVT LTD | THANE | 2 | $4K | Injection | Africa |
| 7 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $3K | Injection | Asia |
| 8 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 4 | $2K | Injection | Asia, Africa |
| 9 | BIOZENTA LIFESCIENCE PVT LTD | Una | 2 | $2K | Injection | Asia, Africa |
| 10 | CITRO PHARMA PVT LTD | BANGALORE | 4 | $2K | Injection | Africa |
| 11 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $2K | Injection | Asia |
| 12 | OCEAN PHARMACEUTICAL | VADODARA | 2 | $1K | Injection | Asia |
| 13 | BRUCK PHARMA PVT LTD | NANI | 3 | $1K | Injection | Oceania, Africa |
| 14 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $980.99 | Injection | Africa |
| 15 | NAPROD LIFE SCIENCES PVT LTD | MUMBAI | 1 | $909.97 | hydrochloride | Asia |
| 16 | AMRS HEALTHCARE PVT LTD | NOIDA | 4 | $427.95 | Injection | Americas |
| 17 | PHARMEDA HEALTHCARE PVT LTD | NEW DELHI | 1 | $389.64 | Injection | Africa |
| 18 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $341.33 | Injection | Africa |
| 19 | DROPS PHARMA PVT LTD | HOSDURG | 1 | $278.15 | Injection | Asia |
| 20 | ZAHIDI ENTERPRISE | CHINCHBUNDER | 1 | $273.92 | Injection | Africa |
| 21 | RUN MEDWAY | SURAT | 2 | $267.24 | Injection | Africa |
| 22 | J.A. UNITED EXPORTS PVT LTD | VASHI | 1 | $191.24 | Injection | Asia |
| 23 | V S INTERNATIONAL PVT LTD | Mumbai | 1 | $177.26 | Injection | Africa |
| 24 | S. HIMATLAL HEALTHCARE LLP | MUMBAI | 1 | $4.92 | Injection | Africa |
| 25 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $0.862 | Injection | Africa |
| 26 | MCARE IMPEX PVT LTD | Aligarh | 1 | $0.0000 | Injection | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 20 global epirubicin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian epirubicin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | CSP P/O VIATRIS SA | France | 4 | $279K | MYLAN LABORATORIES LTD | Injection |
| 2 | MYLAN IRELAND LTD | Netherlands | 1 | $138K | MYLAN LABORATORIES LTD | Solution |
| 3 | PHARMASTAR INTL TRADING CORP | Philippines | 1 | $18K | ADMAC LIFESCIENCES | Injection |
| 4 | M.E.L.S.B | Malaysia | 1 | $17K | VENUS REMEDIES LTD | Injection |
| 5 | LOTUS PHARMA | Burundi | 2 | $4K | KHANDELWAL LABORATOR… | Injection |
| 6 | BANK OF CEYLON-TRADE SERVICES | Sri Lanka | 1 | $3K | UNITED BIOTECH PVT LTD | Injection |
| 7 | VISION CARE INTERNATIONAL PVT LTD | Nepal | 2 | $2K | GETWELL PHARMA INDIA… | Injection |
| 8 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $2K | JMB PHARMACEUTICALS … | Injection |
| 9 | GREBN SIGNALCO LTD | Myanmar | 1 | $1K | ADMAC LIFESCIENCES | Injection |
| 10 | ANSYNC GLOBAL FZCO | United Arab Emirates | 2 | $1K | OCEAN PHARMACEUTICAL | Injection |
| 11 | DKM PHARMACEUTICALS PVT LTD | Nepal | 1 | $909.97 | NAPROD LIFE SCIENCES… | hydrochloride |
| 12 | NIKHIL PHARMA PVT LTD | Nepal | 3 | $361.98 | UNITED BIOTECH PVT LTD | Injection |
| 13 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $278.15 | DROPS PHARMA PVT LTD | Injection |
| 14 | SALAMA NIGERIA LTD | Benin | 1 | $273.92 | ZAHIDI ENTERPRISE | Injection |
| 15 | NDZENGUE EBEDE JEAN JOEL | Cameroon | 2 | $267.24 | RUN MEDWAY | Injection |
| 16 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 1 | $191.24 | J.A. UNITED EXPORTS … | Injection |
| 17 | TAIWO ADEYEMI | Nigeria | 1 | $177.26 | V S INTERNATIONAL PV… | Injection |
| 18 | EUROFINS BIOPHARMA PRODUCT TESTIN | Hungary | 1 | $13.77 | INTAS PHARMACEUTICAL… | Injection |
| 19 | HANITRA RAZAOARIMANANA | Madagascar | 2 | $1.90 | GETWELL PHARMA INDIA… | Injection |
| 20 | BAWABAT ALDAWA MEDICINEES STORE LLC | United Arab Emirates | 1 | $0.0000 | MCARE IMPEX PVT LTD | Injection |
This report covers 55 2025-Q4 Epirubicin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/epirubicin
Talk to our trade analyst
Need a custom epirubicin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/epirubicin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Epirubicin product page
Live data, supplier directory, price trends, and trade route analysis